Marisol Castillo-Castrejon
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta | 7 | 2022 | 78 | 2.520 |
Why?
|
| Pregnancy | 15 | 2026 | 1219 | 0.850 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2023 | 10 | 0.820 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 43 | 0.810 |
Why?
|
| Pregnancy Proteins | 1 | 2021 | 9 | 0.710 |
Why?
|
| Pregnancy in Diabetics | 1 | 2021 | 21 | 0.700 |
Why?
|
| Preconception Care | 1 | 2021 | 17 | 0.690 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 633 | 0.680 |
Why?
|
| Birth Weight | 1 | 2021 | 63 | 0.680 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2021 | 82 | 0.660 |
Why?
|
| Adiposity | 1 | 2021 | 94 | 0.660 |
Why?
|
| Lipids | 1 | 2021 | 214 | 0.620 |
Why?
|
| Carrier Proteins | 1 | 2021 | 252 | 0.610 |
Why?
|
| Amino Acids | 1 | 2019 | 85 | 0.600 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2021 | 301 | 0.590 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 109 | 0.580 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 155 | 0.580 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 68 | 0.580 |
Why?
|
| Dietary Supplements | 1 | 2021 | 265 | 0.570 |
Why?
|
| Insulin Resistance | 1 | 2019 | 176 | 0.560 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 472 | 0.550 |
Why?
|
| Insulin | 1 | 2019 | 324 | 0.550 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 340 | 0.530 |
Why?
|
| Decidua | 2 | 2013 | 4 | 0.520 |
Why?
|
| Trophoblasts | 3 | 2020 | 14 | 0.480 |
Why?
|
| Chorion | 1 | 2013 | 4 | 0.420 |
Why?
|
| Lymphocyte Subsets | 1 | 2013 | 8 | 0.420 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 82 | 0.410 |
Why?
|
| Air Pollution | 3 | 2023 | 18 | 0.390 |
Why?
|
| Female | 16 | 2026 | 15472 | 0.390 |
Why?
|
| Inflammation | 4 | 2023 | 642 | 0.360 |
Why?
|
| Fetus | 2 | 2026 | 79 | 0.280 |
Why?
|
| Premature Birth | 2 | 2021 | 57 | 0.260 |
Why?
|
| Cytokines | 4 | 2019 | 448 | 0.260 |
Why?
|
| Humans | 16 | 2026 | 28585 | 0.240 |
Why?
|
| Immune Tolerance | 1 | 2026 | 52 | 0.240 |
Why?
|
| Indoles | 1 | 2026 | 110 | 0.220 |
Why?
|
| Proteomics | 2 | 2023 | 192 | 0.220 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2015 | 54 | 0.220 |
Why?
|
| Microbiota | 1 | 2026 | 98 | 0.210 |
Why?
|
| Estrogens | 1 | 2023 | 56 | 0.200 |
Why?
|
| Bacteria | 1 | 2026 | 286 | 0.200 |
Why?
|
| Ligands | 1 | 2023 | 178 | 0.200 |
Why?
|
| Weight Gain | 1 | 2023 | 75 | 0.200 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 42 | 0.190 |
Why?
|
| Estradiol | 1 | 2023 | 175 | 0.190 |
Why?
|
| Zika Virus | 1 | 2022 | 28 | 0.190 |
Why?
|
| Zika Virus Infection | 1 | 2022 | 28 | 0.190 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2022 | 47 | 0.180 |
Why?
|
| Infant, Newborn | 2 | 2021 | 899 | 0.170 |
Why?
|
| Developing Countries | 1 | 2021 | 49 | 0.170 |
Why?
|
| Obesity | 2 | 2023 | 675 | 0.170 |
Why?
|
| Adult | 4 | 2021 | 7922 | 0.170 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2020 | 1 | 0.160 |
Why?
|
| Flame Retardants | 1 | 2020 | 2 | 0.160 |
Why?
|
| Pregnancy Trimester, First | 1 | 2020 | 14 | 0.160 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 5 | 0.160 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2020 | 21 | 0.160 |
Why?
|
| Chorionic Villi | 1 | 2019 | 7 | 0.160 |
Why?
|
| Fetal Macrosomia | 1 | 2019 | 3 | 0.160 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2020 | 28 | 0.160 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 28 | 0.160 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 35 | 0.160 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 44 | 0.160 |
Why?
|
| Vagina | 1 | 2019 | 42 | 0.150 |
Why?
|
| Cervix Uteri | 1 | 2019 | 65 | 0.150 |
Why?
|
| Phosphorylation | 1 | 2019 | 581 | 0.140 |
Why?
|
| Cell Movement | 1 | 2020 | 373 | 0.140 |
Why?
|
| Fetal Growth Retardation | 2 | 2020 | 32 | 0.140 |
Why?
|
| Mice | 2 | 2023 | 4735 | 0.130 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2015 | 4 | 0.120 |
Why?
|
| Labor, Obstetric | 1 | 2015 | 11 | 0.120 |
Why?
|
| Leukocytes | 1 | 2015 | 72 | 0.120 |
Why?
|
| Inflammation Mediators | 2 | 2013 | 166 | 0.120 |
Why?
|
| Animals | 3 | 2023 | 10583 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2013 | 1009 | 0.110 |
Why?
|
| Cellular Microenvironment | 1 | 2013 | 6 | 0.110 |
Why?
|
| Term Birth | 1 | 2013 | 10 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2013 | 61 | 0.100 |
Why?
|
| Fetal Development | 1 | 2013 | 25 | 0.100 |
Why?
|
| Adaptive Immunity | 1 | 2013 | 38 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2013 | 59 | 0.100 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 45 | 0.100 |
Why?
|
| Environmental Monitoring | 1 | 2012 | 66 | 0.090 |
Why?
|
| Pregnancy Trimesters | 2 | 2021 | 5 | 0.080 |
Why?
|
| Tryptophan | 1 | 2026 | 42 | 0.060 |
Why?
|
| Male | 1 | 2021 | 13772 | 0.060 |
Why?
|
| Anthropometry | 1 | 2023 | 93 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2023 | 79 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2023 | 106 | 0.050 |
Why?
|
| Papio anubis | 1 | 2022 | 48 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 272 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2020 | 31 | 0.040 |
Why?
|
| Infant | 1 | 2023 | 1019 | 0.040 |
Why?
|
| Wound Healing | 1 | 2020 | 126 | 0.040 |
Why?
|
| Reference Values | 1 | 2019 | 199 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 893 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2020 | 259 | 0.040 |
Why?
|
| Cell Line | 1 | 2020 | 698 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 988 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2019 | 405 | 0.030 |
Why?
|
| Child | 1 | 2023 | 2271 | 0.030 |
Why?
|
| Enzyme Precursors | 1 | 2015 | 16 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 267 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 156 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 416 | 0.030 |
Why?
|
| Vehicle Emissions | 1 | 2013 | 6 | 0.030 |
Why?
|
| Extraembryonic Membranes | 1 | 2013 | 1 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2013 | 5 | 0.020 |
Why?
|
| Air Pollutants | 1 | 2013 | 18 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2013 | 28 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2013 | 36 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2013 | 45 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2013 | 22 | 0.020 |
Why?
|
| Cell Separation | 1 | 2013 | 55 | 0.020 |
Why?
|
| Parturition | 1 | 2013 | 17 | 0.020 |
Why?
|
| Mexico | 1 | 2012 | 91 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2013 | 58 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2013 | 140 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 166 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2013 | 131 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 291 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 2804 | 0.020 |
Why?
|
| Biomarkers | 1 | 2012 | 770 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2012 | 1272 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 1600 | 0.020 |
Why?
|
| Risk Factors | 1 | 2012 | 2111 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 1455 | 0.020 |
Why?
|